Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia

BACKGROUND: Renal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find out promising novel biomarkers for effective treatment. The goal of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Karim, Sajjad, Al-Maghrabi, Jaudah A., Farsi, Hasan M. A., Al-Sayyad, Ahmad J., Schulten, Hans-Juergen, Buhmeida, Abdelbaset, Mirza, Zeenat, Al-boogmi, Alaa A., Ashgan, Fai T., Shabaad, Manal M., NourEldin, Hend F., Al-Ghamdi, Khalid B. M., Abuzenadah, Adel, Chaudhary, Adeel G. A., Al-Qahtani, Mohammed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073805/
https://www.ncbi.nlm.nih.gov/pubmed/27766950
http://dx.doi.org/10.1186/s12885-016-2775-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073805/
https://www.ncbi.nlm.nih.gov/pubmed/27766950
http://dx.doi.org/10.1186/s12885-016-2775-2

Ejemplares similares